Industry Reports
The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers
The ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system more >
The 2025-26 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
The most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry. more >
From The Drug Channels Blog
Friday, March 20, 2026
Medical Benefit Maximizers Are Emerging as a Critical Market Force: What Manufacturers Need to Understand
Today’s guest post comes from Michael Harris, Vice President of Patient Support Services Strategy at Valeris. Michael explores the rise of medical benefit maximizers as a new—and often overlooked—force more >
Tuesday, March 17, 2026
The Top 15 U.S. Pharmacies of 2025: Market Shares and Revenues at the Biggest Chains, PBMs, and Specialty Pharmacies
Next week, the Drug Channels Institute (DCI) will release our 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers. This 17th edition provides our most comprehensive and up-to-date examination more >